Advertisement
Screener

Orthofix Medical Inc. (OFIX) Graph

OFIX Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $210.93M; Cost of revenue $61.23M; Research and development $15.94M; Selling, general and administrative $138.03M.
  • 2026-03-31: Revenue $196.71M; Cost of revenue $57.16M; Research and development $15.32M; Selling, general and administrative $134.91M.
  • 2025-12-31: Revenue $219.91M*; Cost of revenue $63.57M*; Research and development $15.37M*; Selling, general and administrative $136.75M*.
  • 2025-09-30: Revenue $205.63M; Cost of revenue $57.11M; Research and development $14.77M; Selling, general and administrative $148.10M.

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

OFIX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Non Us$40.90MOther Countries$23.70MBR$1.92MDE$2.32MFR$3.27MGB$3.69MIT$6.00MUS$170.03MRevenue$210.93MCost of revenue$61.23MGross profit$149.71MOperating income-$8.13MOther income, net-$778.00KResearch & development$15.94MSelling, general& administrative$138.03MPre-tax income-$15.00MIncome tax$801.00KNet income-$15.80M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

OFIX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Global LimbReconstruction$37.69MGlobal Spine$173.24MRevenue$210.93MCost of revenue$61.23MGross profit$149.71MOperating income-$8.13MOther income, net-$778.00KResearch & development$15.94MSelling, general& administrative$138.03MPre-tax income-$15.00MIncome tax$801.00KNet income-$15.80M

Subsegments

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

OFIX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Spinal Implants BiologicsAnd Enabling Technologies$109.09MTherapeutic Solutions$64.15MRevenue$210.93MCost of revenue$61.23MGross profit$149.71MOperating income-$8.13MOther income, net-$778.00KResearch & development$15.94MSelling, general& administrative$138.03MPre-tax income-$15.00MIncome tax$801.00KNet income-$15.80M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$210.93M$61.23M$15.94M$138.03M(m)$801.00K-$15.80M
2026-03-31$196.71M$57.16M$15.32M$134.91M(m)$74.00K-$20.91M
2025-12-31$219.91M*$63.57M*$15.37M*$136.75M*(m)$30.00K*-$2.22M*
2025-09-30$205.63M$57.11M$14.77M$148.10M(m)$533.00K-$22.80M
2025-06-30$203.12M$63.59M$15.93M$136.49M(m)-$142.00K-$14.08M
2025-03-31$193.65M$72.03M$19.77M$132.98M(m)$961.00K-$53.09M
2024-09-30$196.61M$61.55M$17.29M$130.14M$10.89M$751.00K-$27.39M
2024-06-30$198.62M$63.87M$18.05M$134.22M$11.23M$1.08M-$33.44M
2024-03-31$188.61M$61.37M$19.49M$131.69M(m)$851.00K-$36.02M
2023-09-30$184.01M$64.24M$18.56M(m)$9.55M$472.00K-$28.86M
2023-06-30$187.02M$67.47M$19.42M(m)$11.20M$1.51M-$39.43M
2023-03-31$175.20M$64.88M$23.31M(m)(m)$611.00K-$60.94M
2022-09-30$114.00M$30.57M$11.94M(m)(m)$1.34M-$10.72M
2022-06-30$118.07M$31.60M$12.76M(m)(m)$553.00K$2.49M
2022-03-31$106.42M$28.32M$11.21M(m)(m)$71.00K-$4.46M
2021-09-30$112.43M$28.31M$12.36M(m)(m)-$364.00K-$2.17M
2021-06-30$121.39M$27.44M$13.12M(m)(m)$2.25M$2.42M
2021-03-31$105.59M$25.91M$10.90M(m)(m)-$207.00K-$5.82M
2020-09-30$110.98M$26.24M$9.96M(m)(m)$607.00K$4.65M
2020-06-30$73.14M$23.17M$8.77M(m)(m)$1.59M-$18.42M
2020-03-31$104.82M$23.41M$9.96M(m)(m)-$20.03M$25.66M
2019-12-31$121.49M$26.19M(m)(m)$91.21M(m)$11.69M
2019-09-30$113.50M$24.90M$7.98M(m)$107.48M$13.66M-$40.50M
2019-06-30$115.85M$25.81M$8.98M(m)$89.59M$1.22M-$547.00K
2019-03-31$109.11M$23.71M$9.23M(m)$89.85M-$6.01M$897.00K
2018-12-31$121.08M$25.63M(m)(m)$83.05M(m)$8.87M
2018-09-30$111.71M$24.02M$9.60M(m)$83.78M-$117.00K-$1.21M
2018-06-30$111.55M$22.84M$7.89M(m)$82.80M$1.10M$925.00K
2018-03-31$108.71M$24.15M$6.94M(m)$76.69M$5.37M$5.23M
2017-12-31$116.90M$23.56M(m)(m)$75.47M(m)$1.57M
2017-09-30$105.25M$23.72M$6.93M(m)$72.50M$6.15M$3.46M
2017-06-30$108.94M$23.18M$6.89M(m)$77.77M$3.92M$3.85M
2017-03-31$102.74M$22.58M$7.42M(m)$74.24M$3.92M-$2.65M
2016-12-31$108.54M$23.32M(m)(m)$77.80M(m)-$3.24M
2016-09-30$98.50M$19.88M$6.86M(m)$69.35M-$1.28M$9.90M
2016-06-30$104.08M$22.52M$6.80M(m)$84.25M$3.69M-$7.44M
2016-03-31$98.68M$22.14M$7.64M(m)$69.47M$4.29M$3.84M
2015-12-31$104.62M$21.41M(m)(m)$75.83M(m)$3.37M
2015-09-30$101.15M$23.86M$6.52M(m)$73.15M$3.07M-$1.37M
2015-06-30$100.95M$21.91M$6.45M(m)$74.12M$1.78M$3.57M
2015-03-31$89.76M$19.34M$5.84M(m)$77.61M$964.00K-$8.38M
2014-12-31$100.28M$21.46M(m)(m)$74.87M(m)-$5.80M
2014-09-30$100.99M$25.27M$6.57M(m)$69.22M$4.76M$452.00K
2014-06-30$100.98M$25.41M$6.31M(m)$68.87M$3.31M-$683.00K
2014-03-31$100.01M$26.77M$5.93M(m)$73.27M$1.18M-$2.51M
2013-12-31$105.89M$34.12M(m)(m)$81.84M(m)-$10.41M
2013-09-30$91.81M$25.06M$6.36M(m)$80.84M$383.00K-$18.84M
2013-06-30$97.64M$21.88M$8.55M(m)$68.84M$3.25M-$3.01M
2013-03-31$102.28M$25.84M$5.74M(m)$70.37M$4.36M$3.45M
2012-12-31$115.61M$26.75M(m)(m)$62.34M(m)$22.95M
2012-09-30$105.82M$24.89M$6.86M(m)$63.99M$6.75M$3.75M
2012-06-30$111.60M$24.94M$9.25M(m)$70.04M$3.82M$8.80M
2012-03-31$107.16M$24.14M$7.05M(m)$68.23M$6.47M$7.35M
2011-12-31$118.64M$27.30M(m)(m)$83.17M(m)$7.89M
2011-09-30$111.51M$23.13M$5.98M(m)$67.42M$7.98M$10.07M
2011-06-30$108.22M$22.75M$6.23M(m)$73.10M$6.34M$5.39M
2011-03-31$103.61M$22.35M$6.05M(m)$116.86M$6.25M-$41.47M
2010-12-31$143.80M(m)(m)(m)(m)(m)$7.96M
2010-09-30$138.91M$32.27M$7.38M(m)$87.65M$5.77M$8.52M
2010-06-30$142.84M$34.09M$8.37M(m)$87.55M$6.54M$10.23M
2010-03-31$138.82M(m)(m)(m)(m)(m)$17.49M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$407.64M$118.39M$31.26M$272.94M(m)$875.00K-$36.71M
2025-06-30$396.77M$135.62M$35.70M$269.47M(m)$819.00K-$67.17M
2024-06-30$387.23M$125.24M$37.54M$265.91M$21.97M$1.94M-$69.46M
2023-06-30$362.22M$132.34M$42.73M(m)$23.02M$2.12M-$100.36M
2022-06-30$224.49M$59.92M$23.97M(m)(m)$624.00K-$1.97M
2021-06-30$226.99M$53.35M$24.02M(m)(m)$2.04M-$3.40M
2020-06-30$177.96M$46.58M$18.73M(m)(m)-$18.44M$7.24M
2019-06-30$224.96M$49.52M$18.21M(m)(m)-$4.79M$350.00K
2018-06-30$220.26M$46.98M$14.83M(m)(m)$6.47M$6.15M
2017-06-30$211.68M$45.76M$14.31M(m)(m)$7.85M$1.20M
2016-06-30$202.75M$44.65M$14.44M(m)$153.61M$7.98M-$3.60M
2015-06-30$190.72M$41.25M$12.30M(m)$151.73M$2.74M-$4.81M
2014-06-30$201.00M$52.19M$12.25M(m)$142.14M$4.49M-$3.19M
2013-06-30$199.92M$47.73M$14.29M(m)$139.21M$7.61M$436.00K
2012-06-30$222.36M$48.92M$16.30M(m)$141.22M$10.29M$16.66M
2011-06-30$229.73M$45.53M$11.67M(m)$192.31M$12.06M-$25.84M
2010-06-30$281.67M$66.78M$15.90M(m)$161.73M$15.16M$27.72M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$602.40M$192.73M$50.47M$417.58M(m)$1.35M-$89.97M
2024-09-30$583.83M$186.79M$54.84M$396.05M$32.85M$2.69M-$96.85M
2023-09-30$546.23M$196.58M$61.29M(m)$32.57M$2.59M-$129.22M
2022-09-30$338.48M$90.49M$35.91M(m)(m)$1.97M-$12.69M
2021-09-30$339.42M$81.66M$36.38M(m)(m)$1.68M-$5.57M
2020-09-30$288.94M$72.82M$28.69M(m)(m)-$17.83M$11.89M
2019-09-30$338.46M$74.42M$26.19M(m)(m)$8.87M-$40.15M
2018-09-30$331.96M$71.00M$24.43M(m)(m)$6.35M$4.94M
2017-09-30$316.93M$69.47M$21.25M(m)(m)$14.00M$4.66M
2016-09-30$301.25M$64.53M$21.29M(m)$223.07M$6.70M$6.29M
2015-09-30$291.87M$65.11M$18.82M(m)$224.88M$5.81M-$6.18M
2014-09-30$301.99M$77.45M$18.82M(m)$211.35M$9.25M-$2.74M
2013-09-30$291.73M$72.79M$20.65M(m)$220.05M$7.99M-$18.40M
2012-09-30$330.22M$73.31M$23.16M(m)$205.88M$17.04M$21.68M
2011-09-30$347.04M$69.38M$17.66M(m)$262.16M$20.04M-$13.46M
2010-09-30$420.57M$99.05M$23.27M(m)$249.38M$20.93M$36.24M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$822.31M$256.30M$65.85M$554.33M(m)$1.38M-$92.19M
2024-12-31$799.49M$253.61M$73.64M$532.52M(m)$2.12M-$126.00M
2023-12-31$746.64M$260.37M$80.23M$530.39M(m)$2.72M-$151.40M
2022-12-31$460.71M$123.54M$49.06M$308.78M(m)$2.04M-$19.75M
2021-12-31$464.48M$114.91M$49.62M(m)(m)$24.88M-$38.38M
2020-12-31$406.56M$101.89M$39.06M(m)(m)-$2.88M$2.52M
2019-12-31$459.95M$100.61M$34.64M(m)$378.13M$1.41M-$28.46M
2018-12-31$453.04M$96.63M$33.22M(m)$326.32M$9.07M$13.81M
2017-12-31$433.82M$93.04M$29.70M(m)$299.98M$29.10M$6.22M
2016-12-31$409.79M$87.85M$28.80M(m)$300.87M$15.53M$3.06M
2015-12-31$396.49M$86.53M$26.39M(m)$300.71M$10.85M-$2.81M
2014-12-31$402.28M$98.91M$24.99M(m)$286.23M$16.20M-$8.54M
2013-12-31$397.61M$106.91M$26.77M(m)$301.89M$7.60M-$28.81M
2012-12-31$440.19M$100.73M$28.58M(m)$264.59M$23.94M$42.85M
2011-12-31$435.52M$96.42M$22.86M(m)$332.49M$14.44M-$17.70M
2010-12-31$462.57M$97.09M$27.96M(m)$299.49M-$6.03M$44.30M
2009-12-31$545.63M$138.45M$31.46M(m)$343.31M$15.55M(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
CARLSMED, INC. (CARL)United States$0.405B
Embecta Corp. (EMBC)United States$0.319B2.10
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Mobia Medical, Inc. (MOBI)United States$0.293B
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Cytosorbents Corp (CTSO)United States$0.274B-1.29
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26